Occupational Medicines Market Brief Analysis On Top Key players Like Amgen, Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly, F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer, Inc., and Sanofi

The global occupational medicines market is driven by the surge in awareness about occupational health. Moreover, favorable regulatory environment and rapid increase in aging workforce are the key factors that augment the growth of the market. However, emergence of small businesses, change in industry structure, and rise in incorporation of artificial intelligence (AI) and automation in the industry are some of the factors that restrain the market growth. On the contrary, the presence of untapped markets in the developing nations is expected to provide new opportunities for the key players.

The global occupational medicines market was valued at $3,753 million in 2017, and is estimated to reach $5,794 million by 2025, registering a CAGR of 5.5% from 2018 to 2025.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4728

Occupational medicine is a branch of medicine concerned with treatment of work-related diseases; for instance, exposure to second-hand smoke and cancer-causing chemicals in the petroleum & mining industry workers is the cause of diseases, such as chronic obstructive pulmonary disease (COPD), skin infections, muscle pains, chemical poisoning, cancer, and others.

The global occupational medicine market is expected to grow considerably during the forecast period, owing to various factors, such as rise in awareness related to occupational health, rapid growth in geriatric workforce, and favorable regulatory environment towards occupational medicine. However, increasing adoption of automation and artificial intelligence (AI) in industries and emerging small businesses along with change in industry structure are the key factors that are expected to hinder the market growth. On the contrary, emerging markets, such as China and India, are anticipated to provide lucrative growth opportunities to the market players during the forecast period.

By application, the musculoskeletal disorder segment accounted for one-third share of the global occupational medicines market in 2017. Furthermore, the construction segment is anticipated to grow at the highest rate of 7.3% during the forecast period.

Key Findings of the Occupational Medicines Market:

-North America occupied almost one-fourth share of the global occupational medicine market.
-The construction segment is anticipated to grow with the highest CAGR throughout the forecast period.
-Europe is anticipated to occupy almost two-fifths market share of the global occupational medicine market by 2025.
-The Asia-Pacific region is anticipated to grow at the highest rate during the forecast period, followed by LAMEA.

Europe was the leading revenue contributor to the global occupational medicines market in 2017, owing to European regulatory framework for occupational medicines and occupational health that insists greatly on monitoring health and safety of workers in the work environment. However, the Asia-Pacific region is expected to grow at the highest CAGR of 7.4% from 2018 to 2025, owing to increase in disposable income, surge in research, development, and innovation activities, and rise in awareness towards occupational health.

The report provides an extensive competitive analysis and profiles of the key market players, such as
-Amgen, Inc.,
-AstraZeneca PLC,
-Bristol-Myers Squibb Company,
-Eli Lilly and Company,
-F. Hoffmann-La Roche Ltd,
-Johnson & Johnson,
-Nestl S.A. (Galderma S.A.),
-Novartis AG,
-Pfizer, Inc., and
-Sanofi.

The other players in the value chain (not included in the report) include Merck & Co., Inc., AbbVie, Inc., and GlaxoSmithKline plc.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/4728

Table Of Content

Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective

Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in awareness about occupational health
3.4.1.2. Favorable regulatory environment
3.4.1.3. Rapid increase in aging workforce
3.4.2. Restraints
3.4.2.1. Emergence of small businesses and change in industry structure
3.4.2.2. Rise in incorporation of artificial intelligence (AI) and automation in the industry
3.4.3. Opportunity
3.4.3.1. Untapped potential of the emerging economies

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/occupational-medicines-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.